# Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

> **NCT00176592** · PHASE4 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 75 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Betaseron
- **DRUG:** Copaxone

## Key facts

- **NCT ID:** NCT00176592
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176592, "Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00176592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*